HIMS Stock Forecast & Price Target

Hims & Hers Health has demonstrated significant growth, with a notable 55% year-over-year increase in members utilizing personalized products, contributing to 65% of total membership as of the third quarter of FY25. The company shows promising future revenue projections, estimating international revenue could rise nearly tenfold to almost $1 billion by FY30, driven by expanding treatment options and improving user experience. Additionally, Hims & Hers anticipates a robust annual growth rate of approximately 21% in core U.S. revenue, bolstered by subscriber growth and higher revenue per subscriber through personalized services and new treatment offerings.

Hims & Hers Health has experienced significant volatility in its stock performance, with shares up more than 100% year-to-date but down over 20% since late July, highlighting concerns about slowing core growth. Key issues contributing to a negative outlook include slower adoption of personalized treatments, heightened competition in the digital health space, and the potential impact of evolving regulations on its business model. Additionally, the company faces risks associated with reliance on consumers' financial health, which could impact revenue if macroeconomic conditions deteriorate.